(Q36352068)

13 August 2017

1 reference

title

An overview of uterine cancer and its management (English)

1 reference

13 August 2017

cervix uterine cancer

1 reference

Jonathan Carter

1

1 reference

PubMed ID

16375642

13 August 2017

Selvan Pather

series ordinal

2

1 reference

13 August 2017

1 January 2006

1 reference

Expert Review of Anticancer Therapy

13 August 2017

1 reference

13 August 2017

6

1 reference

13 August 2017

1

1 reference

13 August 2017

33-42

1 reference

13 August 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Recent advances in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Carcinoma of the corpus uteri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Endometrial adenocarcinoma--presenting pathology is a poor guide to surgical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

The Society of Gynecologic Oncologists Outcomes Task Force. Study of endometrical cancer: initial experiences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Surgical staging of gynecologic malignancies: the role of laparoscopy and sentinel node technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Sentinel lymph node detection in patients with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Advances in the treatment of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

The use of sentinel lymph nodes in gynaecological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Outcomes of laparoscopic treatment for endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Laparoscopic lymphadenectomy for gynecologic malignancies using ultrasonically activated shears: analysis of first 100 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Laparoscopic pelvic and paraaortic lymphadenectomy in gynecologic oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Laparoscopy compared with laparotomy for the surgical staging of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in stages I and II endometrial cancer. Operating data, follow up and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Can photon IMRT be improved by combination with mixed electron and photon techniques?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Differences in Treatment and Outcome Between African-American and White Women With Endometrial Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Adjuvant progestagen therapy for the treatment of endometrial cancer: review and meta-analyses of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

A critical evaluation of follow-up of women treated for endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

The role of routine follow-up after gynecological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Risk-specific follow-up for endometrial carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.1.33

21 January 2018

Identifiers

DOI

10.1586/14737140.6.1.33

1 reference

13 August 2017

1 reference

PubMed ID

16375642